Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
A pullback to the buy point is a normal, albeit frustrating, part of investing in growth stocks. Roughly 40% of successful stocks go back around their buy point before resuming their advance, so be ready for this situation. You should see a gradual price decline with weaker volume as the stock returns to or just below the buy point.
Axcelis Technology could be an incredibly inexpensive bet on the future of power chips.
Based on the average brokerage recommendation (ABR), Axcelis (ACLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Axcelis Technologies is one of the cheapest stocks in the chip sector, and it's packed with long-term potential.
Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences:
Axcelis Technologies, Inc. (NASDAQ:ACLS) Q1 2024 Earnings Call Transcript May 2, 2024 Axcelis Technologies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen and welcome to the Axcelis Technologies Call to discuss the Company’s Results […]
Axcelis Technologies ( NASDAQ:ACLS ) First Quarter 2024 Results Key Financial Results Revenue: US$252.4m (flat on 1Q...
Robust Q1 results with a 10% increase in EPS and significant revenue contributions from China and power devices segments.
Axcelis (ACLS) delivers healthy Q1 performance driven by momentum in the implant-intensive power device segment, especially silicon carbide and solid shipments to China.
Comprehensive Analysis of ACLS's Financial Performance in Q1 2024